MGTX
Price
$6.61
Change
-$0.06 (-0.90%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
533.63M
40 days until earnings call
RGNX
Price
$8.39
Change
-$0.36 (-4.11%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
422.76M
32 days until earnings call
Interact to see
Advertisement

MGTX vs RGNX

Header iconMGTX vs RGNX Comparison
Open Charts MGTX vs RGNXBanner chart's image
MeiraGTx Holdings
Price$6.61
Change-$0.06 (-0.90%)
Volume$20.25K
Capitalization533.63M
REGENXBIO
Price$8.39
Change-$0.36 (-4.11%)
Volume$34.87K
Capitalization422.76M
MGTX vs RGNX Comparison Chart in %
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. RGNX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a StrongBuy and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (MGTX: $6.64 vs. RGNX: $8.39)
Brand notoriety: MGTX and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 161% vs. RGNX: 104%
Market capitalization -- MGTX: $533.63M vs. RGNX: $422.76M
MGTX [@Biotechnology] is valued at $533.63M. RGNX’s [@Biotechnology] market capitalization is $422.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 6 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • MGTX’s TA Score: 6 bullish, 5 bearish.
  • RGNX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than RGNX.

Price Growth

MGTX (@Biotechnology) experienced а +4.73% price change this week, while RGNX (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

MGTX is expected to report earnings on Aug 07, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($534M) has a higher market cap than RGNX($423M). MGTX YTD gains are higher at: 9.031 vs. RGNX (8.538). RGNX has higher annual earnings (EBITDA): -122.44M vs. MGTX (-141.78M). RGNX has more cash in the bank: 268M vs. MGTX (66.5M). RGNX (79.8M) and MGTX (80.9M) have identical debt. RGNX has higher revenues than MGTX: RGNX (157M) vs MGTX (34.5M).
MGTXRGNXMGTX / RGNX
Capitalization534M423M126%
EBITDA-141.78M-122.44M116%
Gain YTD9.0318.538106%
P/E RatioN/AN/A-
Revenue34.5M157M22%
Total Cash66.5M268M25%
Total Debt80.9M79.8M101%
FUNDAMENTALS RATINGS
MGTX vs RGNX: Fundamental Ratings
MGTX
RGNX
OUTLOOK RATING
1..100
7453
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
4160
P/E GROWTH RATING
1..100
10021
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGNX's Valuation (73) in the Biotechnology industry is in the same range as MGTX (74). This means that RGNX’s stock grew similarly to MGTX’s over the last 12 months.

RGNX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that RGNX’s stock grew similarly to MGTX’s over the last 12 months.

RGNX's SMR Rating (97) in the Biotechnology industry is in the same range as MGTX (99). This means that RGNX’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (41) in the Biotechnology industry is in the same range as RGNX (60). This means that MGTX’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's P/E Growth Rating (21) in the Biotechnology industry is significantly better than the same rating for MGTX (100). This means that RGNX’s stock grew significantly faster than MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXRGNX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIAYX29.690.12
+0.41%
Diamond Hill Long-Short Y
CSSVX28.830.10
+0.35%
Carillon Chartwell Small Cap R-6
SNGRX24.61N/A
N/A
Sit International Growth
WAMCX31.01N/A
N/A
Wasatch Ultra Growth
FIWCX11.45N/A
N/A
Fidelity SAI International Value Index